Public recall detail

Jamp-Rehydralyte: Pouch sealing issue that may affect the stability of affected batches.

2023-07-28

medium
Recall Safety notice
Quick summary

Quick summary: Jamp-Rehydralyte: Pouch sealing issue that may affect the stability of affected batches.. Date: 2023-07-28.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Jamp-Rehydralyte: Pouch sealing issue that may affect the stability of affected batches.. Date: 2023-07-28.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandJamp-Rehydralyte
ProductJamp-Rehydralyte
IssueHealth products - Product quality
Recall classType II
IdentificationRA-74024

Affected products

BrandJamp-Rehydralyte
ProductJamp-Rehydralyte
DIN / NPN / authorizationNPN 80027403
Dosage formPower for Solution
Strength2-Hydroxy-1,2,3-propanetricarboxylic acid sodium salt (1:3) 530.0 mg / sachet, 2-Hydroxy-1,2,3-propanetricarboxylic acid tripotassium salt 390.0 mg / sachet, D-glucose 3560.0 mg / sachet, Sodium Chloride 470.0 mg / sachet
Lot4201 4204 8081 8082 8091 12091

Issue

Pouch sealing issue that may affect the stability of affected batches.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products
CompaniesJamp Pharma Corporation 1310 Nobel, Boucherville Québec, J4B 5H3
DistributionNational
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-74024
Background{}
CompaniesJamp Pharma Corporation 1310 Nobel, Boucherville Québec, J4B 5H3
AudiencesGeneral public Healthcare Industry
Source updated2023-07-28

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...